Medical, tech entrepreneurs launch matchmaking effort in life sciences
Three entrepreneurs from the medical and software realms are herding angels to invest in upstart life sciences companies in
Indiana.
Health Care & Life Sciences
Articles
Investment losses leave Conseco searching for $400M in horrible environment to raise capital
Without fresh capital â?? or loosened debt obligations â?? Carmel-based Conseco could find itself in bankruptcy or looking
for a buyer or both.
Stimulus bill could prompt physician mergers
Now that Medicare is calling for all doctors it deals with to use electronic medical records by 2015, the trend of physicians’
merging with hospitals or larger groups could hasten.
Attorneys with doctorates in high demand
Lawyers holding doctorates in biotech, biology, chemistry and computer sciences are in high demand by firms with strong intellectual
property practices.
Purdue student venture fund invests in Kylin Therapeutics
Purdue University’s Student-Managed Venture Fund is betting its bank on West Lafayette-based biotech startup Kylin Therapeutics
Inc.
Health care IT firms rushing to grab share of stimulus
The stimulus bill has prompted Indiana businesses and not-for-profits that deal in medical records to look for partners to
help them meet the challenge of making those records electronic in five years.
Inspired by column
Thank you for sharing Dr. Mercy Obeime’s story so that others may feel they too can overcome any obstacles and adversities.
Wells leaves as Medicaid chief with cost-cutting plan in limbo
Dr. Jeff Wells is moving on from the Indiana Medicaid program even as a $40 million cost-savings plan he spearheaded faces
a threat in the Legislature.
Lilly relying on technology to spot management talent
An electronic succession-planning system created by Eli Lilly & Co. about seven years ago is sniffing out top talent.
Let’s set record straight on benefits
The insurance industry and [Indiana] Chamber of Commerce are providing misleading and untruthful statements to employers and
their insured members about assignment of benefits.
Nursing home column was on target
I want to commend [Tawn Parent’s Feb. 16 column] about overseeing a loved one’s care while in a nursing home or rehab facility.
Pulliam Trust sponsors support for addicts
The recovery experts at Fairbanks Alcohol and Drug Treatment Center last year launched a recovery management program, thanks to a $200,000 grant from the Nina Mason Pulliam Charitable Trust.
AIT Laboratories named ‘Small Business of the Year’
The Indiana Chamber of Commerce has named Indianapolis-based health care research and testing firm AIT Laboratories its 2009
Small Business of the Year.
Dow may need to sell Indy’s Dow AgroSciences
Financially strapped Dow Chemical Co. acknowledges it may sell Indianapolis-based Dow AgroSciences LLC, the ag-chemicals-and-biotech
firm that’s one of the biggest jewels in the city’s life sciences crown.
Are we victims of ‘group think’?
“Group think,” a powerful and controlling force, was present as the Capital Improvement Board built Lucas Oil Stadium and Eli Lilly and Co. developed and marketed Zyprexa.
Startup NICO raises another $1.73M
Indianapolis-based medical-device startup NICO Corp. has raised $1.73 million from investors.
Cook splits device unit to focus on cancer products
Cook Medical has split its interventional devices business into two units, pulling its lesser known cancer products out from under the shadow of its heart products.
Grants will shrink, life sciences leader predicts
Last fall, BioCrossroads named Leonard J. Betley—chairman of the Richard M. Fairbanks Foundation, the Regenstrief Foundation
and the Walther Cancer Foundation—its inaugural Life Sciences Champion of the Year. IBJ recently caught up with Betley to get his thoughts on the latest life sciences developments and gauge the climate
for fund raising.
Legislation takes aim at Anthem
Anthem Blue Cross and Blue Shield’s growing market dominance in Indiana is sparking a backlash from doctors who plan to push
a bill this year in the Indiana General Assembly that would allow physicians to reject patients covered by massive health
insurer.
Lilly makes $6.5B acquisition
Eli Lilly and Co. CEO John Lechleiter played a game of pharmaceutical poker with former Lilly Chief Financial Officer Jim
Cornelius—and won.